Seminar highlights | Durham, NC
When
May 8, 2025
2:30 p.m. - Registration
3:00 p.m. - Panel Discussion
5:00 p.m. - Networking with refreshments
Where
North Carolina Biotechnology Center
15 TW Alexander Dr
Durham, NC 27713
Fee: No Cost.
Limited Seats.
Register below.
Featured Presentations
From Bench to Bioreactor: Translating RNA Modifications into Vaccine Innovations
Fadi Marayati, PhD
RNA Scientist, Duke Human Vaccine Institute
Fadi Marayati is an mRNA Scientist at the Duke Human Vaccine Institute, where he focuses on developing mRNA vaccines for infectious diseases. Prior to joining DHVI, he completed his postdoctoral training at the Duke University School of Medicine, where he developed the first real-time, genetically encoded RNA modification sensor—a technology that was featured on the cover of Nature Biotechnology. Fadi holds a PhD in Molecular Biology and Biochemistry from Wake Forest University, where his research centered on RNA regulation and chromatin organization, earning him the Outstanding Graduate Student Award.
Journey through the world of RNA vaccines and therapeutics Explore saRNA, CRISPR, and modified nucleotides
Stephanie Ramos, PhD
VP of R&D, Biology TriLink Biotechnologies
Stephanie Ramos is the Vice President of R&D, Biology at TriLink Biotechnologies, where she leads efforts to advance nucleic acid technologies for a range of therapeutic applications. She holds a Ph.D. in Molecular Biology from UC Irvine and brings over 15 years of biotechnology and pharmaceutical industry experience spanning preclinical discovery, IND-enabling studies, and clinical assay development through Phase III trials. Stephanie has worked extensively across nucleic acid-based vaccines, immunotherapeutics, small molecules, and biologics for indications including autoimmunity, infectious diseases, and cancer.
Questions?
Email us at marketing@trilinkbiotech.com
TriLink BioTechnologies does not sell or distribute your information to third parties. For more information, please refer to our Privacy Policy